Clinical manifestations in neuropathologically defined subgroups of vascular dementia

Ulla Andin1, Lars Gustafson, Arne Brun

  • 1Department of Psychogeriatrics, Lund University Hospital, Sweden. ulla.andin@orebroll.se

Insights

This study analyzed clinical features across vascular dementia (VaD) subgroups. Large Vessel Dementia (LVD) showed the highest prevalence of cardiovascular features, aiding diagnostic understanding.

Area of Science:

  • Neurology
  • Pathology
  • Gerontology

Background:

  • Vascular Dementia (VaD) encompasses diverse neuropathological subtypes.
  • Clinical manifestations can vary significantly among these subtypes, impacting diagnosis and management.
  • Understanding these differences is crucial for targeted therapeutic strategies.

Purpose of the Study:

  • To investigate cardio-cerebrovascular disease and clinical features in neuropathologically defined VaD subgroups.
  • To compare clinical presentations, including falls, dizziness, and cognitive changes, across pure Small Vessel Dementia (SVD), SVD-Alzheimer's disease (SVD-AD), Large Vessel Dementia (LVD), and Hypoxic Hypoperfusive Dementia (HHD).

Main Methods:

  • Analysis of 175 neuropathologically verified VaD cases.
  • Selection of pure SVD (n=36), SVD-AD (n=38), pure LVD (n=7), and pure HHD (n=6) subgroups.
  • Evaluation of cardio-cerebrovascular features, hypertension, transient ischemic attacks (TIA), and complete cerebrovascular lesions (CVL).

Main Results:

  • No significant differences in cardiovascular symptoms, hypertension, TIA, or CVL between pure SVD and SVD-AD groups.
  • Marked variation in cardiovascular features across pure VaD subgroups, with LVD exhibiting the highest prevalence.
  • Hypertension was common in LVD and SVD but rare in HHD; TIA/CVL were most frequent in LVD.

Conclusions:

  • Significant clinical similarities and differences exist between pathologically defined VaD subgroups.
  • Findings contribute to understanding the etiopathogenesis and diagnosis of VaD.
  • Provides a basis for developing targeted treatment strategies for VaD.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...